This page contains exclusive content for the member of the following sections: TTS. Log in to view.
New Immunosuppressive Agents
123.7 - The Role of Proteasome Inhibition with Bortezomib in the Treatment of Antibody Mediated Rejection (AMR) after Renal Transplantation
Presenter: Stuart, Flechner, Cleveland, United States Authors: Flechner S.
Important
Disclaimer
By viewing the material on this site you understand and
accept that:
The opinions and statements expressed on this site reflect the
views of the author or authors and do not necessarily reflect those of
The Transplantation Society and/or its Sections.
The hosting of material on The Transplantation Society site does
not signify endorsement of this material by The Transplantation Society
and/or its Sections.
The material is solely for educational purposes for qualified
health care professionals.
The Transplantation Society and/or its Sections are not liable for
any decision made or action taken based on the information contained in
the material on this site.
The information cannot be used as a substitute for professional
care.
The information does not represent a standard of care.
No physician-patient relationship is being established.